Jie Xu

机构：The University of Texas MD Anderson Cancer Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, The University of Texas Health Science Center at Houston · ORCID：0000-0002-1897-1644

发表论文 78 篇 · 总被引 686 次 · h-index 15

代表论文

• Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia (2024 · American Journal of Hematology · 被引 36)
• Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial (2024 · The Lancet Haematology · 被引 29)
• Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid Leukemia (2025 · American Journal of Hematology · 被引 20)
• Systemic ALK-negative anaplastic large cell lymphoma: Insights into morphologic, immunophenotypic, genetic and molecular characteristics (2024 · Human Pathology · 被引 11)
• Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement (2024 · American Journal of Clinical Pathology · 被引 6)
• Radiotherapy in the treatment of primary cutaneous CD4 + small/medium T‐cell lymphoproliferative disorder (2024 · International Journal of Dermatology · 被引 5)